Surgery Partners, Inc. (SGRY) - What Are Brokerages Saying About This Stock?

Key Points

• Analyst sentiment is moderately bullish: Eleven brokerages give Surgery Partners an average “Moderate Buy” rating, with seven buys, three holds and one sell. The average 12-month price target is $19, versus a recent share price of $14.71.
• Institutional and insider activity has been supportive: Several investment firms increased their holdings, including HSBC, which boosted its position by 54.5%. Director Teresa DeLuca also bought 10,000 shares at an average price of $14.35.
• Recent quarterly results exceeded expectations: Surgery Partners reported earnings of $0.10 per share versus the $0.06 consensus estimate, while revenue of $848.9 million surpassed forecasts and rose 2.7% year over year. However, the company reported a negative net margin of 2.63%.

Shares of Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) have earned an average recommendation of "Moderate Buy" from the eleven ratings firms that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and seven have given a buy recommendation to the company. The average 12 month target price among brokerages that have covered the stock in the last year is $19.00.

A number of research analysts have recently issued reports on the stock. TD Cowen reiterated a "buy" rating and set a $19.00 price target on shares of Surgery Partners in a research note on Friday, September 18th. Raymond James Financial set a $18.00 price objective on shares of Surgery Partners in a research report on Tuesday, August 11th. Benchmark reaffirmed a "buy" rating on shares of Surgery Partners in a report on Tuesday, August 11th. Zacks Research lowered Surgery Partners from a "strong-buy" rating to a "hold" rating in a report on Monday, August 10th. Finally, Royal Bank Of Canada reiterated an "outperform" rating and set a $19.00 target price on shares of Surgery Partners in a research report on Wednesday, September 30th.

Insider Activity at Surgery Partners

In related news, Director Teresa DeLuca acquired 10,000 shares of the firm's stock in a transaction that occurred on Tuesday, August 18th. The shares were purchased at an average price of $14.35 per share, with a total value of $143,500.00. Following the completion of the acquisition, the director owned 66,843 shares in the company, valued at approximately $959,197.05. This represents a 17.59% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. 2.00% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. TD Waterhouse Canada Inc. grew its position in shares of Surgery Partners by 18.3% in the third quarter. TD Waterhouse Canada Inc. now owns 196,887 shares of the company's stock valued at $2,601,000 after purchasing an additional 30,476 shares during the last quarter. Squarepoint Ops LLC purchased a new position in shares of Surgery Partners during the 2nd quarter worth approximately $308,000. Varde Management L.P. increased its stake in shares of Surgery Partners by 32.8% during the 2nd quarter. Varde Management L.P. now owns 1,003,447 shares of the company's stock worth $16,858,000 after purchasing an additional 248,009 shares in the last quarter. Penn Capital Management Company LLC acquired a new position in shares of Surgery Partners during the 2nd quarter worth approximately $2,941,000. Finally, Hsbc Holdings PLC raised its position in shares of Surgery Partners by 54.5% during the 2nd quarter. Hsbc Holdings PLC now owns 2,958,912 shares of the company's stock worth $48,912,000 after purchasing an additional 1,043,244 shares during the last quarter.

Surgery Partners Stock Performance

Shares of SGRY opened at $14.71 on Tuesday. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.78 and a current ratio of 1.95. The stock has a market capitalization of $1.93 billion, a P/E ratio of -21.01, a P/E/G ratio of 4.52 and a beta of 1.90. The company's fifty day moving average is $14.17 and its two-hundred day moving average is $14.48. Surgery Partners has a 1 year low of $11.41 and a 1 year high of $23.44.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last released its earnings results on Monday, August 10th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of $0.06 by $0.04. The company had revenue of $848.90 million during the quarter, compared to analysts' expectations of $830.03 million. Surgery Partners had a negative net margin of 2.63% and a positive return on equity of 0.88%. The business's revenue was up 2.7% on a year-over-year basis. During the same quarter last year, the business earned $0.17 EPS. On average, sell-side analysts predict that Surgery Partners will post 0.25 earnings per share for the current year.

Surgery Partners Company Profile

Surgery Partners, Inc NASDAQ: SGRY is a healthcare services company that operates and manages ambulatory surgery centers and surgical hospitals in partnership with physicians and health systems. Its facilities provide scheduled surgical care in outpatient and inpatient settings, with an emphasis on procedures that generally do not require extended hospital stays.

The company supports a range of specialties, including orthopedics, pain management, ophthalmology, gastroenterology, gynecology, and general surgery.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.